{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:51:57Z","timestamp":1790009517280,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.vaccine.2005.04.023","type":"journal-article","created":{"date-parts":[[2005,7,6]],"date-time":"2005-07-06T21:15:31Z","timestamp":1120684531000},"page":"4500-4508","source":"Crossref","is-referenced-by-count":35,"title":["Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency"],"prefix":"10.1016","volume":"23","author":[{"given":"Fubao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Puddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill C.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonise A.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"McMackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthi J.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2005.04.023_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.023_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-85-20825","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"85","author":"Hilleman","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2005.04.023_bib3","series-title":"Fields virology","first-page":"2111","article-title":"Adenoviridae: the viruses and their replication","author":"Shenk","year":"1996"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.023_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2005.04.023_bib5","first-page":"389","article-title":"Construction of first-generation adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2005.04.023_bib6","series-title":"Adenoviral vectors for gene therapy","article-title":"Adenoviral vector construction II: bacterial systems","author":"Lusky","year":"2002"},{"key":"10.1016\/j.vaccine.2005.04.023_bib7","doi-asserted-by":"crossref","unstructured":"Edelstein. Gene therapy clinical trials worldwide 1989\u20132004\u2014an overview. J Gene Med 2004;6(6):597\u2013602.","DOI":"10.1002\/jgm.619"},{"issue":"11","key":"10.1016\/j.vaccine.2005.04.023_bib8","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2005.04.023_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.04.023_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1021106116887","article-title":"Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells","volume":"38","author":"Gueret","year":"2002","journal-title":"Cytotechnology"},{"issue":"5","key":"10.1016\/j.vaccine.2005.04.023_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2144\/00285bm08","article-title":"Accelerated titering of adenoviruses","volume":"28","author":"Bewig","year":"2000","journal-title":"Biotechniques"},{"issue":"11","key":"10.1016\/j.vaccine.2005.04.023_bib12","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/nar\/26.11.2821","article-title":"A high-throughput hybridization method for titer determination of viruses and gene therapy vectors","volume":"26","author":"Atkinson","year":"1998","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2005.04.023_bib13","series-title":"Keystone Symposium on HIV-1 Vaccine Development. Banff, Canada","article-title":"Ongoing development and evaluation of a potential HIV-1 vaccine using a replication-defective adenoviral vector","author":"Emini","year":"2003"},{"key":"10.1016\/j.vaccine.2005.04.023_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.55.091902.104344","article-title":"Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors","volume":"55","author":"Shiver","year":"2004","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.04.023_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/nar\/28.2.655","article-title":"3\u2032-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures","volume":"28","author":"Kutyavin","year":"2000","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2005.04.023_bib16","series-title":"Probit analysis","author":"Finney","year":"1971"},{"issue":"2","key":"10.1016\/j.vaccine.2005.04.023_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jviromet.2004.01.009","article-title":"Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR","volume":"117","author":"Schalk","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2005.04.023_bib18","series-title":"Strip-plot designs, mixed models and comparisons between linear and nonlinear models for microtiter plate bioassays","author":"Lansky","year":"2002"},{"issue":"15","key":"10.1016\/j.vaccine.2005.04.023_bib19","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.04.023_bib20","series-title":"Fifth Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Products","article-title":"Novel use of QPCR technology to assay the potency of live virus vaccines. in Well Characterized Biological Products","author":"Lewis","year":"2001"},{"key":"10.1016\/j.vaccine.2005.04.023_bib21","unstructured":"Ranheim TS, Mathis PK, Joelsson DB et al. Development and application of a quantitative RT-QPCR assay for a multivalent rotavirus vaccine (Rotateq). 2004;Manuscript in preparation."},{"issue":"2","key":"10.1016\/j.vaccine.2005.04.023_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14712598.1.2.177","article-title":"Alphavirus vectors: development and potential therapeutic applications","volume":"1","author":"Schlesinger","year":"2001","journal-title":"Exp Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T04:51:34Z","timestamp":1586321494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05004627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":22,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0264410X05004627"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.04.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}